Ignite Creation Date:
2025-12-24 @ 9:31 PM
Ignite Modification Date:
2026-03-29 @ 3:24 PM
Study NCT ID:
NCT01696032
Status:
COMPLETED
Last Update Posted:
2024-08-27
First Post:
2012-09-26
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
SGI-110 in Combination With Carboplatin in Ovarian Cancer
Sponsor:
Astex Pharmaceuticals, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
SGI-110-02
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None